Oncolytics Biotech Other Operating Expenses (Quarterly) Analysis

Oncolytics Biotech, Inc. (ONCY)

1.145 +0.08 (+8.02%) USD | NASDAQ | Feb 24, 16:00

1.16 +0.02 (+1.31%) After-Hours: 20:00

View Other Operating Expenses (Quarterly) for ONCY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Operating Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Operating Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Operating Expenses (Quarterly) Benchmarks

Start Trial

Aurinia Pharmaceuticals, Inc.	Upgrade
Edesa Biotech, Inc.	Upgrade
Lexaria Bioscience Corp.	--
Xenon Pharmaceuticals, Inc.	--
ProMIS Neurosciences, Inc.	--